Condition: Benign Prostatic Hyperplasia · Sponsor: Urotronic Inc.
The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.
This description comes directly from the study's public registry record.
Kaitlyn Palm · 612-816-0068 · kpalm@laborie.com
Steve Madej · smadej@laborie.com
Always discuss trial participation with your own doctor first.
| Arkansas Urology | Little Rock, Arkansas, United States | Recruiting |
| Florida Urology Partners, LLP | Tampa, Florida, United States | Recruiting |
| Ochsner LSU Health Shreveport - Regional Urology | Shreveport, Louisiana, United States | Recruiting |
| Sheldon Freedman MD, Ltd | Las Vegas, Nevada, United States | Recruiting |
| Oregon Urology Institute | Springfield, Oregon, United States | Recruiting |
| Midtown Urology Associates | Austin, Texas, United States | Recruiting |
| Houston Methodist Urology Associates | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06312722